Concise informed consent to increase data and biospecimen access may accelerate innovative Alzheimer's disease treatments
{{output}}
Introduction: Informed consent forms that restrict the distribution of data and samples have been an impediment to advancing Alzheimer's disease (AD) understandings and treatments. The Coalition Against Major Disease public-priva... ...
